Tempus AI (NASDAQ:TEM) Trading 3% Higher – What’s Next?

Tempus AI, Inc. (NASDAQ:TEM) shot up 3% during trading on Thursday . The company traded as high as $55.60 and last traded at $54.86. 3,916,729 shares were traded during trading, a decline of 24% from the average session volume of 5,169,968 shares. The stock had previously closed at $53.25.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on TEM. Loop Capital reduced their price target on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a research report on Tuesday, January 14th. Guggenheim reissued a “buy” rating on shares of Tempus AI in a research note on Tuesday, February 25th. Needham & Company LLC raised their price target on Tempus AI from $56.00 to $70.00 and gave the stock a “buy” rating in a research note on Tuesday, February 25th. Wolfe Research lowered shares of Tempus AI from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, February 26th. Finally, TD Cowen reissued a “buy” rating and set a $74.00 price target (up previously from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $61.18.

Tempus AI Trading Down 0.2 %

The business has a 50-day simple moving average of $57.78 and a 200-day simple moving average of $51.47. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17.

Insider Activity

In related news, major shareholder Bradley A. Keywell sold 265,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were sold at an average price of $35.10, for a total transaction of $9,301,500.00. Following the completion of the transaction, the insider now owns 15,218,365 shares in the company, valued at $534,164,611.50. This represents a 1.71 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Ryan M. Bartolucci sold 13,770 shares of Tempus AI stock in a transaction dated Friday, January 31st. The stock was sold at an average price of $60.00, for a total value of $826,200.00. Following the completion of the sale, the chief accounting officer now owns 57,237 shares in the company, valued at approximately $3,434,220. The trade was a 19.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 5,598,969 shares of company stock worth $317,194,162 in the last quarter.

Institutional Trading of Tempus AI

Large investors have recently made changes to their positions in the company. Kovitz Investment Group Partners LLC purchased a new stake in Tempus AI during the 3rd quarter valued at about $1,367,000. Victory Capital Management Inc. purchased a new stake in shares of Tempus AI in the fourth quarter valued at approximately $216,000. China Universal Asset Management Co. Ltd. acquired a new stake in shares of Tempus AI in the fourth quarter valued at approximately $1,091,000. Mirae Asset Global Investments Co. Ltd. purchased a new position in Tempus AI during the fourth quarter worth approximately $178,000. Finally, Captrust Financial Advisors acquired a new position in Tempus AI during the third quarter worth $2,726,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.